263 related articles for article (PubMed ID: 25356587)
1. The association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review.
Zhang L; Han J; Wu H; Liang X; Zhang J; Li J; Xie L; Xie Y; Sheng X; Yu J
PLoS One; 2014; 9(10):e110626. PubMed ID: 25356587
[TBL] [Abstract][Full Text] [Related]
2. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
[TBL] [Abstract][Full Text] [Related]
3. miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression.
Fu Y; Sun LQ; Huang Y; Quan J; Hu X; Tang D; Kang R; Li N; Fan XG
Curr Mol Med; 2018; 18(3):135-141. PubMed ID: 30198432
[TBL] [Abstract][Full Text] [Related]
4. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994
[TBL] [Abstract][Full Text] [Related]
5. High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.
Liu F; Zhang Y; Peng Z; Gao H; Xu L; Chen M
J Transl Med; 2012 Jul; 10():135. PubMed ID: 22747650
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of combining high mobility group Box-1 and OV-6 expression in hepatocellular carcinoma.
Zhu J; Yu H; Chen S; Yang P; Dong Z; Ling Y; Tang H; Bai S; Yang W; Tang L; Shen F; Wang H; Wen W
Sci China Life Sci; 2018 Aug; 61(8):912-923. PubMed ID: 29441453
[TBL] [Abstract][Full Text] [Related]
7. High-mobility group box 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma.
Jiang W; Wang Z; Li X; Fan X; Duan Y
Pathol Oncol Res; 2012 Apr; 18(2):293-8. PubMed ID: 21953322
[TBL] [Abstract][Full Text] [Related]
8. The EpCAM overexpression is associated with clinicopathological significance and prognosis in hepatocellular carcinoma patients: A systematic review and meta-analysis.
Zhou L; Zhu Y
Int J Surg; 2018 Aug; 56():274-280. PubMed ID: 29936198
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis.
Li JH; Ma WJ; Wang GG; Jiang X; Chen X; Wu L; Liu ZS; Zeng XT; Zhou FL; Yuan YF
Front Immunol; 2018; 9():2077. PubMed ID: 30254644
[No Abstract] [Full Text] [Related]
10. Clinical Implication of the Relationship Between High Mobility Group Box-1 and Tumor Differentiation in Hepatocellular Carcinoma.
Ando K; Sakoda M; Ueno S; Hiwatashi K; Iino S; Minami K; Kawasaki Y; Hashiguchi M; Tanoue K; Mataki Y; Kurahara H; Maemura K; Shinchi H; Natsugoe S
Anticancer Res; 2018 Jun; 38(6):3411-3418. PubMed ID: 29848691
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes.
Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY
Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570
[TBL] [Abstract][Full Text] [Related]
12. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
13. Low levels of glycoprotein 96 indicate a worse prognosis in early-stage hepatocellular carcinoma patients after hepatectomy.
Ji F; Zhang Y; Zhu ZB; Guo Y; Shen SL; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
Hum Pathol; 2019 Apr; 86():193-202. PubMed ID: 30529751
[TBL] [Abstract][Full Text] [Related]
14. Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance.
Ma HX; Shu QH; Pan JJ; Liu D; Xu GL; Li JS; Ma JL; Jia WD; Yv JH; Ge YS
Tumour Biol; 2015 Jun; 36(6):4235-41. PubMed ID: 25592379
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis.
Xiao WK; Qi CY; Chen D; Li SQ; Fu SJ; Peng BG; Liang LJ
BMC Cancer; 2014 Feb; 14():104. PubMed ID: 24548704
[TBL] [Abstract][Full Text] [Related]
16. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
Li J; Gao JZ; Du JL; Wei LX
World J Gastroenterol; 2014 May; 20(20):6336-44. PubMed ID: 24876756
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
19. HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review.
Wu T; Zhang W; Yang G; Li H; Chen Q; Song R; Zhao L
Oncotarget; 2016 Aug; 7(31):50417-50427. PubMed ID: 27391431
[TBL] [Abstract][Full Text] [Related]
20. High‑mobility group box 1 has a prognostic role and contributes to epithelial mesenchymal transition in human hepatocellular carcinoma.
Liu Z; Dou C; Wang Y; Jia Y; Li Q; Zheng X; Yao Y; Liu Q; Song T
Mol Med Rep; 2015 Oct; 12(4):5997-6004. PubMed ID: 26252226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
